Quest Diagnostics (DGX) FY2021 results: revenue $10.8 billion, up 14.3% on the year
Quest Diagnostics Inc. (DGX) reported revenue of $10.8 billion for fiscal 2021, the year ended 31 December 2021, up 14.3% on the year before. Net income was $2.0 billion, up 39.4%, and diluted earnings per share $15.55. The figures are the company's own, from the 10-K it filed with the SEC on 28 February 2022.
Revenue
$10.8 billion
+14.3% on the year
FY2014FY2021
Operating margin
22.1%
20.9% a year earlier
FY2014FY2021
Net income
$2.0 billion
+39.4% on the year
FY2014FY2021
Diluted EPS
$15.55
+48.5% on the year
FY2014FY2021
this yearthe year beforeHover a bar for its figure.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Operating cash flow
2,233
2,005
1,243
+11.4%
Capital expenditure
403
418
400
-3.6%
Free cash flow
1,830
1,587
843
+15.3%
Free cash flow margin
17.0%
16.8%
10.9%
Cash from investing
21.0
-772
-411
Cash from financing
-2,540
-1,267
225
Depreciation and amortisation
408
361
329
+13.0%
Share-based compensation
79.0
97.0
56.0
-18.6%
Buybacks
2,199
325
353
+576.6%
Dividends paid
309
297
286
+4.0%
Diluted shares, weighted
128m
136m
136m
-5.9%
Balance sheet
$ million
FY2021
FY2020
FY2019
On the year
Last 8 years
Shareholders' equity
6,444
6,759
5,641
-4.7%
Non-controlling interest
39.0
50.0
46.0
-22.0%
Redeemable equity
79.0
82.0
76.0
-3.7%
Debt
4,012
4,015
4,770
-0.1%
Operating lease liabilities
494
499
413
-1.0%
Finance lease liabilities
32.0
25.0
30.0
+28.0%
Other liabilities
2,511
2,596
1,867
-3.3%
Total liabilities and equity
13,611
14,026
12,843
-3.0%
Fixed assets
1,707
1,627
1,453
+4.9%
Goodwill
7,095
6,873
6,619
+3.2%
Intangible assets
1,167
1,167
1,121
0.0%
Securities held for sale or to maturity
1.0
12.0
12.0
-91.7%
Cash and equivalents
872
1,158
1,192
-24.7%
Receivables
1,438
1,520
1,063
-5.4%
Inventory
208
223
123
-6.7%
Other assets
1,123
1,446
1,260
-22.3%
Total assets
13,611
14,026
12,843
-3.0%
10-K for the year ended 31 December 2021, filed 28 February 2022: the filing.